Skip to main content
. 2023 Aug 16;5(11):100881. doi: 10.1016/j.jhepr.2023.100881

Table 3.

Adjusted odds ratios (95% CI) summarising the multivariable association of covariates with presence of sarcopenia at four time points.

Covariate Baseline Year 1 Year 2 Year 3
Older age 1.43 (1.09–1.93) 1.32 (0.92–1.93) 1.06 (0.67–1.68) 1.62 (0.95–2.98)
MELD at LT 0.96 (0.93–0.98)
DM pre-LT 0.77 (0.31–1.75) 0.73 (0.36–1.47) 0.71 (0.32–1.56) 0.31 (0.11–0.79)
CKD pre-LT 0.24 (0.04–0.87) 2.26 (0.61–9.66) 1.37 (0.32–6.05)
Male sex 2.94 (1.71–5.23) 2.11 (1.06–4.30) 0.84 (0.36–2.00) 0.98 (0.35–2.74)
Higher BMI 1.00 (0.95–1.06) 0.98 (0.91–1.05)
Any rehab within 90 days from LT 2.02 (0.99–4.20) 1.23 (0.55–2.76)
Tacrolimus Exposure 0.93 (0.72–1.19) 0.99 (0.74–1.33)
Baseline sarcopenia 8.47 (3.80–20.70) 5.78 (2.43–14.80) 11.47 (4.01–37.91)

The text in bold is statistically significant.

Year 1 scan done 180–-365 days after LT. CKD, chronic kidney disease; DM, diabetes mellitus; LT, liver transplant; MELD, model for end-stage liver disease.